The diagnostic value of serum levels of VEGF, bFGF and endostatin in patients with liver cancer

被引：0
|
作者：
Nikopoulou, A.
Makrantonakis, P.
Karamouzis, M.
Nikolaidis, P.
Agorastos, J.
Nikopoulos, A.
Giannoulis, E.
机构：
[1] Ahepa Univ Hosp, Thessaloniki, Greece
[2] Ippokratio Univ Hosp, Thessaloniki, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21133
引用
收藏
页数：2
相关论文
共 50 条
  • [1] bFGF and VEGF serum levels in breast cancer patients and healthy women: useful as diagnostic tools?
    Volpi, A
    Granato, AM
    Nanni, O
    Falcini, F
    Folli, S
    De Paola, F
    Medri, L
    Mosconi, G
    Amadori, D
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S95 - S95
  • [2] Predictive value of the efficacy of treatment with letrozole of endostatin and bFGF serum levels.
    Alba, E
    Gonzalez, FJ
    Antonio, L
    Ramon, C
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S134 - S134
  • [3] Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD
    Pavlisa, Gordana
    Pavlisa, Goran
    Kusec, Vesna
    Kolonic, Slobodanka Ostojic
    Markovic, Asja Stipic
    Jaksic, Branimir
    [J]. EUROPEAN CYTOKINE NETWORK, 2010, 21 (02) : 92 - 98
  • [4] Are serum angiogenic (VEGF and BFGF) and antiangiogenic (endostatin) factors predictive of clinical outcome in patients with lymphomas?
    Girinsky, T.
    Abou Yared, J.
    Koscielny, S.
    Ceapa, S.
    Griscelli, F.
    Ferme, C.
    Ghalibafian, M.
    Carde, P.
    Ribrag, V.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 169 - 170
  • [5] The expression and diagnostic value of serum levels of EphA2 and VEGF-A in patients with colorectal cancer
    Wang, Ganbiao
    Wang, Yigao
    Yang, Xiaodong
    Zhang, Yaqin
    Lu, Yida
    Li, Yongxiang
    [J]. CANCER BIOMARKERS, 2021, 31 (04) : 399 - 408
  • [6] Serum endostatin levels in patients with epithelial ovarian cancer
    Hata, K
    Dhar, DK
    Kanasaki, H
    Nakayama, K
    Fujiwaki, R
    Katabuchi, H
    Okamura, H
    Nagasue, N
    Miyazaki, K
    [J]. ANTICANCER RESEARCH, 2003, 23 (2C) : 1907 - 1912
  • [7] VEGF, BFGF & ENDOSTATIN DO NOT PREDICT PROGNOSIS IN HEPATOCELLULAR CARSINOMA PATIENTS
    Sykymbayev, A.
    Eren, F.
    Tiftikci, A.
    Tuere, F.
    Guenduez, F.
    Ozdogan, O.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S234 - S235
  • [8] Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
    R Salgado
    P B Vermeulen
    I Benoy
    R Weytjens
    P Huget
    E Van Marck
    L Y Dirix
    [J]. British Journal of Cancer, 1999, 80 : 892 - 897
  • [9] Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
    Salgado, R
    Vermeulen, PB
    Benoy, I
    Weytjens, R
    Huget, P
    Van Marck, E
    Dirix, LY
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) : 892 - 897
  • [10] Serum endostatin and bFGF as predictive factors in advanced breast cancer patients treated with letrozole
    Alba E.
    Llombart A.
    Ribelles N.
    Ramos M.
    Fernández R.
    Mayordomo J.I.
    Tusquets I.
    Gil M.
    Barnadas A.
    Carabante F.
    Ruiz M.
    Vera R.
    Palomero I.
    Soriano V.
    González J.
    Colomer R.
    [J]. Clinical and Translational Oncology, 2006, 8 (3) : 193 - 199
12345